EUVIMEDEUVIMED entdecken
Crossref

A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection

Junhyup Song iD, Sinyoung Kim iD, Younhee Park iD

Clinical Chemistry · 2024

DOI: 10.1093/clinchem/hvad220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Junhyup Song und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Latent Tuberculosis, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) remains a significant global health concern. Accurate detection of latent TB infection is crucial for effective control and prevention. We aimed to assess the performance of an interferon-gamma release assay blood test (QuantiFERON-TB Gold Plus [QFT-Plus]) in various clinical contexts and identify conditions that affect its results.

Methods

We conducted a retrospective analysis of 31 000 QFT-Plus samples collected from 26 000 subjects at a tertiary hospital in South Korea over a 4-year period and compared the rates of positivity and indeterminate results across diverse clinical situations. We also analysed the contribution of the QuantiFERON TB2 tube to the test’s sensitivity and determined optimal cutoff values for 3 hematologic parameters to distinguish false-negative results. These cutoff values were validated in a separate cohort of subjects with microbiologically confirmed subclinical TB.

Results

Rates of QFT-Plus positivity and indeterminate results were disparate across diagnoses. The TB2 tube increased QFT-Plus sensitivity by 4.1% (95% CI, 1.1%–7.0%) in patients with subclinical TB. Absolute lymphocyte count ≤1.19 × 109/L, absolute neutrophil count ≥5.88 × 109/L, and neutrophil-to-lymphocyte ratio ≥4.33 were effective criteria to discriminate false-negative QFT-Plus results. Application of the hematologic criteria, individually or combined with mitogen response <10 IU/mL, substantially improved performance in the main study cohort and the validation cohort.

Conclusions

These findings highlight the influence of clinical context and patient hematologic profiles on QFT-Plus results. To minimise neglected latent TB infections due to false-negative QFT-Plus results, serial retesting is advisable in patients with severe lymphopenia or neutrophilia, particularly when the mitogen response is <10 IU/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TuberculosisTuberculosisHumansInterferon-gamma Release TestsRetrospective StudiesMitogensHematologic Tests

Substanzen

Mitogens

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

ORCID-Profile: Junhyup Song, Sinyoung Kim, Younhee Park

Zitieren

APA

Song, J., Kim, S., & Park, Y. (2024). A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvad220

Vancouver

Song J, Kim S, Park Y. A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvad220

BibTeX
@article{Song2024,
  author = {Song, Junhyup and Kim, Sinyoung and Park, Younhee},
  title = {A Retrospective Study of Factors Contributing to the Performance of an Interferon-Gamma Release Assay Blood Test for Tuberculosis Infection},
  journal = {Clinical Chemistry},
  year = {2024},
  doi = {10.1093/clinchem/hvad220}
}
Kostenlos starten →